The Scientific Research and Development team at Skyhawk Therapeutics focuses on the discovery and optimization of small molecules that correct RNA splicing and mis-splicing. Leveraging proprietary kinetic, structural, and computational models, this multidisciplinary team advances drug development efforts across various disease areas by conducting high-throughput screening, biochemical and cellular assays, and preclinical studies to ensure the efficacy and safety of potential therapeutics.
Amparo Garcia Lopez
Executive Director Discovery B...
Anna Groner
Senior Principal Scientist
Botao Liu
Executive Director, Bioinforma...
Davide Isaia
Research Associate II
Laurent Brault
Senior Director Discovery Biol...
Loren Berry
Senior Director Of DMPK
Marie-Eve Brault
Director, Discovery Biology
Meghan Miller
Executive Director, Translatio...
Olesia Buiakova
Sr. Director In Vivo Pharmacol...
Sivaraman Dandapani
Director of Chemistry
View all